F
42
2
NWSA
71
-4
CHD
39
2
VFC
58
2
NEE
42
-2
SRE
45
-2
WHR
59
-2
EXR
33
2
LYB
43
6
ICE
57
2
ORLY
48
-4
MNST
59
7
VMC
44
2
CVS
32
3
AAPL
65
-2
HBI
58
2
ESS
51
3
WMT
70
2
JCI
44
2
EQT
45
-3
F
42
2
NWSA
71
-4
CHD
39
2
VFC
58
2
NEE
42
-2
SRE
45
-2
WHR
59
-2
EXR
33
2
LYB
43
6
ICE
57
2
ORLY
48
-4
MNST
59
7
VMC
44
2
CVS
32
3
AAPL
65
-2
HBI
58
2
ESS
51
3
WMT
70
2
JCI
44
2
EQT
45
-3
Financhill
Back

Harmony Biosciences Holdings 10K Form

Sell
33

HRMY
Harmony Biosciences Holdings

Last Price:
$34.08
Seasonality Move:
-6.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRMY News And Ratings

See the #1 stock for the next 7 days that we like better than HRMY

HRMY Financial Statistics

Sales & Book Value

Annual Sales: $582M
Cash Flow: $70.5M
Price / Cash Flow: 9.15
Annual Sales: $10.46
Price / Book: 3.32

Profitability

EPS (TTM): 2.11000
Net Income (TTM): $122.6M
Gross Margin: $460.8M
Return on Equity: 23.59%
Return on Assets: 14.52%

Harmony Biosciences Holdings Earnings Forecast

Key Harmony Biosciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 6 years for HRMY is 79.17%.
  • The Selling, General & Administrative Expenses for HRMY have been equal to 33.11% of Gross Profit Margin.
  • The Research & Development expenses have been 13.07% of Revenue.
  • The Interest Expense is 18.44% of Operating Income.
  • The Net Earning history of HRMY is 22.14% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Harmony Biosciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HRMY
Website: harmonybiosciences.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 3.24
Quick Ratio: 3.05

Price-to-Earnings

Trailing P/E Ratio: 16.3
Forward P/E Ratio: 7.93

HRMY Technical Analysis vs Fundamental Analysis

Sell
33
Harmony Biosciences Holdings (HRMY) is a Sell

Is Harmony Biosciences Holdings a Buy or a Sell?